Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6296-6303
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6296
Figure 1
Figure 1 Kaplan-Meier survival curves for patients (A) and allografts (B). Forty-three patients who underwent LT for end-stage biliary disease and eighty-six case-matched end-stage liver disease patients are compared. LT: Liver transplantation; ESBD: End-stage biliary disease; ESLD: End-stage liver disease.